Cardiovascular disease risk assessment in patients with obstructive sleep apnoea: clinical utility of the Framingham risk equation for initiating statins.
Horwood
F
F
Gruber
A
A
Sithole
J
J
Ali
N
N
Idris
I
I
D002318:Cardiovascular Diseases / Q000209:etiology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D009765:Obesity / Q000150:complications*; D018570:Risk Assessment; D020181:Sleep Apnea, Obstructive / Q000150:complications*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors